Pbx 3a Antibodies

Santa Cruz Biotechnology delivers a wide array of Pbx 3a monoclonal antibodies for research focused on understanding Pbx 3a protein function. Pbx 3a Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Pbx 3a is a member of the pre-B-cell leukemia homeobox (PBX) family of transcription factors, which play a crucial role in regulating gene expression during development and differentiation. Pbx 3a is involved in various biological processes, including hematopoiesis and organogenesis, making it essential for normal cellular function and development. Dysregulation of Pbx 3a has been implicated in several diseases, including cancer, highlighting its importance as a target for therapeutic intervention. Research has shown that Pbx 3a expression patterns vary across different tissue types and developmental stages. Understanding Pbx 3a's molecular interactions and regulatory mechanisms can provide valuable insights into developmental biology and disease pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Pbx 3a's role in health and disease.